Theoretical study reveals charge-transfer dynamics in Ru-Au hybrids for NO detection, suggesting applications in theranostics.
Photoactivatable nitric oxide donors (photoNORMs) are promising agents for con-trolled NO release and real-time optical tracking in biomedical theranostics. Here, we report a comprehensive density functional theory (DFT) and time-dependent DFT (TDDFT) study on a series of hybrid ruthenium–gold nanocluster systems of the gen-eral formula [(L)Ru(NO)(SH)@Au₂₀], where L = salen, bpb, porphyrin, or phthalocya-nine. Structural and bonding analyses reveal that the Ru–NO bond maintains a formal {RuNO}⁶ configuration with pronounced Ru→π*(NO) backbonding, leading to partial reduction of the NO ligand and an elongated N–O bond. NBO, NEDA, and ETS–NOCV analyses confirm that Ru–NO bonding is dominated by charge-transfer and polariza-tion components, while Ru–S and Au–S linkages exhibit delocalized, donor–acceptor character coupling the molecular chromophore with the metallic cluster. TDDFT re-sults reproduce visible–NIR absorption features arising from mixed metal-to-ligand and cluster-mediated charge-transfer transitions. The calculated zero–zero transition and reorganization energies predict NIR-II emission (1.8–3.8 μm), a region of high bi-omedical transparency, making these systems ideal candidates for luminescence-based NO sensing and therapy. This study establishes fundamental design principles for next-generation Ru-based photoNORMs integrated with plasmonic gold nanoclusters, highlighting their potential as multifunctional, optically trackable theranostic platforms.
No takes yet. Share an insight, caveat, or question.
Catevas et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: